[1] |
Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units[J]. JAMA, 2009,302(21):2323⁃2329. doi: 10.1001/jama.2009.1754.
|
[2] |
Puel A. Human inborn errors of immunity underlying superficial or invasive candidiasis[J]. Hum Genet, 2020,139(6⁃7):1011⁃1022. doi: 10.1007/s00439⁃020⁃02141⁃7.
|
[3] |
Glocker EO, Hennigs A, Nabavi M, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections[J]. N Engl J Med, 2009,361(18):1727⁃1735. doi: 10.1056/NEJMoa 0810719.
|
[4] |
Gavino C, Hamel N, Zeng JB, et al. Impaired RASGRF1/ERK⁃mediated GM⁃CSF response characterizes CARD9 deficiency in French⁃Canadians[J]. J Allergy Clin Immunol, 2016,137(4):1178⁃1188.e7. doi: 10.1016/j.jaci.2015.09.016.
|
[5] |
Celmeli F, Oztoprak N, Turkkahraman D, et al. Successful granulocyte colony⁃stimulating factor treatment of relapsing Candida albicans meningoencephalitis caused by CARD9 deficiency[J]. Pediatr Infect Dis J, 2016,35(4):428⁃431. doi: 10.1097/INF.0000000000001028.
|
[6] |
Herbst M, Gazendam R, Reimnitz D, et al. Chronic Candida albicans meningitis in a 4⁃year⁃old girl with a homozygous mutation in the CARD9 gene (Q295X)[J]. Pediatr Infect Dis J, 2015,34(9):999⁃1002. doi: 10.1097/INF.0000000000000736.
|
[7] |
Drummond RA, Franco LM, Lionakis MS. Human CARD9: a critical molecule of fungal immune surveillance[J]. Front Immunol, 2018,9:1836. doi: 10.3389/fimmu.2018.01836.
|
[8] |
Lanternier F, Barbati E, Meinzer U, et al. Inherited CARD9 deficiency in 2 unrelated patients with invasive exophiala infection[J]. J Infect Dis, 2015,211(8):1241⁃1250. doi: 10.1093/ infdis/jiu412.
|
[9] |
Strasser D, Neumann K, Bergmann H, et al. Syk kinase⁃coupled C⁃type lectin receptors engage protein kinase C⁃δ to elicit Card9 adaptor⁃mediated innate immunity[J]. Immunity, 2012,36(1):32⁃42. doi: 10.1016/j.immuni.2011.11.015.
|
[10] |
Wang X, Wang W, Lin Z, et al. CARD9 mutations linked to subcutaneous phaeohyphomycosis and TH17 cell deficiencies[J]. J Allergy Clin Immunol, 2014,133(3):905⁃908.e3. doi: 10. 1016/j.jaci.2013.09.033.
|
[11] |
Drewniak A, Gazendam RP, Tool AT, et al. Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency[J]. Blood, 2013,121(13):2385⁃2392. doi: 10.1182/blood⁃2012⁃08⁃450551.
|
[12] |
Drummond RA, Collar AL, Swamydas M, et al. CARD9⁃dependent neutrophil recruitment protects against fungal invasion of the central nervous system[J]. PLoS Pathog, 2015,11(12):e1005293. doi: 10.1371/journal.ppat.1005293.
|
[13] |
Lanternier F, Pathan S, Vincent QB, et al. Deep dermatophytosis and inherited CARD9 deficiency[J]. N Engl J Med, 2013,369(18):1704⁃1714. doi: 10.1056/NEJMoa1208487.
|
[14] |
Lanternier F, Mahdaviani SA, Barbati E, et al. Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species⁃induced meningoencephalitis, colitis, or both[J]. J Allergy Clin Immunol, 2015,135(6):1558⁃1568.e2. doi: 10.1016/j.jaci.2014.12.1930.
|
[15] |
Gross O, Gewies A, Finger K, et al. Card9 controls a non⁃TLR signalling pathway for innate anti⁃fungal immunity[J]. Nature, 2006,442(7103):651⁃656. doi: 10.1038/nature04926.
|
[16] |
Zhang C, Wang W, Kong Q, et al. Characterization of a Candida albicans isolate from a recurrent cervical lymphadenitis patient[J]. Mycologia, 2019,111(6):942⁃952. doi: 10.1080/00275514. 2019.1666598.
|